November 02, 2020
Ocrevus Still Reigns for Progressive MS, Spherix Reports, But Challenges Noted
From: Multiple Sclerosis News Today
By: Marta Figueiredo
Genentech’s Ocrevus (ocrelizumab) continues to be the most prescribed treatment for people with progressive forms of multiple sclerosis (MS) among U.S. neurologists, according to the latest Spherix Global Insights’ report…(read more).